Sanofi S.A. - Company Overview and Analysis, 2023 Update
Summary
Company Analysis 2023: Sanofi S.A., reports key findings as of 4th August, 2023 based on market analysis and brand diversification by industry and geography.
Sanofi S.A. (Sanofi) is a French healthcare company that develops and markets a wide range of medications. The company is also a manufacturer and marketer of consumer health, cosmetics & toiletries, pet care, and non-alcoholic beverages. Sanofi has presence across all the regions worldwide with major business concentrated in West Europe, which accounted for 25% of value sales in 2022. The US was the key market for the company generating sales of 15.1%, followed by Brazil and Australia.
Scope
West Europe was the leading revenue generating region for Sanofi in 2022
The consumer health industry in North America presents growth prospects for Sanofi
Sanofi’s business in West Europe sees favorable outlook
Sanofi’s sentiment score remained the same in 2023 as in 2022
Reasons to Buy
Understand the challenges and opportunities for a specific company in order to tap into what is really impacting the industry.
Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
Access valuable strategic take-outs to help direct future decision-making and inform new product development.